- Home
- VCEL vs SSII Comparison
VCEL vs SSII Comparison
Compare VCEL & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SSII
- Stock Information
- Founded
- VCEL 1989
- SSII N/A
- Country
- VCEL United States
- SSII India
- Employees
- VCEL N/A
- SSII N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SSII
- Sector
- VCEL Health Care
- SSII
- Exchange
- VCEL Nasdaq
- SSII Nasdaq
- Market Cap
- VCEL 2.1B
- SSII 1.9B
- IPO Year
- VCEL 1997
- SSII N/A
- Fundamental
- Price
- VCEL $41.83
- SSII $6.03
- Analyst Decision
- VCEL Strong Buy
- SSII
- Analyst Count
- VCEL 8
- SSII 0
- Target Price
- VCEL $62.00
- SSII N/A
- AVG Volume (30 Days)
- VCEL 430.3K
- SSII 506.1K
- Earning Date
- VCEL 07-31-2025
- SSII 08-14-2025
- Dividend Yield
- VCEL N/A
- SSII N/A
- EPS Growth
- VCEL 521.85
- SSII N/A
- EPS
- VCEL 0.05
- SSII N/A
- Revenue
- VCEL $238,541,000.00
- SSII $22,132,445.00
- Revenue This Year
- VCEL $23.03
- SSII N/A
- Revenue Next Year
- VCEL $24.52
- SSII N/A
- P/E Ratio
- VCEL $805.02
- SSII N/A
- Revenue Growth
- VCEL 14.80
- SSII 176.60
- 52 Week Low
- VCEL $37.39
- SSII $0.32
- 52 Week High
- VCEL $63.00
- SSII $22.42
- Technical
- Relative Strength Index (RSI)
- VCEL 47.28
- SSII N/A
- Support Level
- VCEL $40.53
- SSII N/A
- Resistance Level
- VCEL $43.57
- SSII N/A
- Average True Range (ATR)
- VCEL 1.67
- SSII 0.00
- MACD
- VCEL -0.10
- SSII 0.00
- Stochastic Oscillator
- VCEL 27.68
- SSII 0.00
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SSII SS Innovations International Inc. Common Stock
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.